DK0720620T3 - Glutathionanaloger og paraloge paneler omfattende glutathionmimetika - Google Patents

Glutathionanaloger og paraloge paneler omfattende glutathionmimetika

Info

Publication number
DK0720620T3
DK0720620T3 DK94929323T DK94929323T DK0720620T3 DK 0720620 T3 DK0720620 T3 DK 0720620T3 DK 94929323 T DK94929323 T DK 94929323T DK 94929323 T DK94929323 T DK 94929323T DK 0720620 T3 DK0720620 T3 DK 0720620T3
Authority
DK
Denmark
Prior art keywords
glutathione
alanine
beta
mimetics
ester
Prior art date
Application number
DK94929323T
Other languages
English (en)
Inventor
Lawrence M Kauvar
Matthew H Lyttle
Original Assignee
Telik Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/126,229 external-priority patent/US5599903A/en
Application filed by Telik Inc filed Critical Telik Inc
Application granted granted Critical
Publication of DK0720620T3 publication Critical patent/DK0720620T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1085—Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
    • C12N9/1088—Glutathione transferase (2.5.1.18)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57496—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving intracellular compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/9116—Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
    • G01N2333/91165—Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5) general (2.5.1)
    • G01N2333/91171—Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5) general (2.5.1) with definite EC number (2.5.1.-)
    • G01N2333/91177—Glutathione transferases (2.5.1.18)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
DK94929323T 1993-09-24 1994-09-23 Glutathionanaloger og paraloge paneler omfattende glutathionmimetika DK0720620T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/126,229 US5599903A (en) 1992-04-03 1993-09-24 Glutathione analogs and paralog panels comprising glutathione mimics
US08/305,993 US5786336A (en) 1991-04-29 1994-09-19 Target-selective protocols based on mimics
PCT/US1994/010797 WO1995008563A1 (en) 1993-09-24 1994-09-23 Glutathione analogs and paralog panels comprising glutathione mimics

Publications (1)

Publication Number Publication Date
DK0720620T3 true DK0720620T3 (da) 2000-08-07

Family

ID=26824416

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94929323T DK0720620T3 (da) 1993-09-24 1994-09-23 Glutathionanaloger og paraloge paneler omfattende glutathionmimetika

Country Status (12)

Country Link
US (1) US5786336A (da)
EP (1) EP0720620B1 (da)
JP (3) JP3503641B2 (da)
AT (1) ATE193302T1 (da)
AU (1) AU693807B2 (da)
CA (1) CA2171453C (da)
DE (1) DE69424678T2 (da)
DK (1) DK0720620T3 (da)
ES (1) ES2148348T3 (da)
GR (1) GR3033230T3 (da)
PT (1) PT720620E (da)
WO (1) WO1995008563A1 (da)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5679643A (en) * 1987-10-13 1997-10-21 Terrapin Technologies, Inc. Glutathione analogs and paralog panels comprising glutathione mimics
US5599903A (en) * 1992-04-03 1997-02-04 Terrapin Technologies, Inc. Glutathione analogs and paralog panels comprising glutathione mimics
US5955432A (en) * 1992-04-03 1999-09-21 Terrapin Technologies, Inc. Metabolic effects of certain glutathione analogs
US5908919A (en) * 1993-10-01 1999-06-01 Terrapin Technologies Urethane mediated, GST specific molecular release systems
DE69633722T2 (de) * 1995-06-07 2005-11-03 TELIK, INC., Palo Alto Stoffwechseleffekt von bestimmten glutation analogen
US5880097A (en) * 1996-01-04 1999-03-09 Terrapin Techologies, Inc. Tethered prodrugs
AU4124697A (en) * 1996-09-02 1998-03-26 Manchester Metropolitan University, The S-blocked glutathiones
AU2226599A (en) * 1998-01-21 1999-08-09 Telik, Inc. Methods to identify myelostimulants
KR100750842B1 (ko) * 1999-01-27 2007-08-22 텔리크 인코포레이티드 글루타티온 유사체를 함유하는 치료 조성물
US6783929B1 (en) 1999-11-02 2004-08-31 Chiron Corporation Biological sample component purification and differential display
US7153682B2 (en) * 2000-06-05 2006-12-26 Chiron Corporation Microarrays on mirrored substrates for performing proteomic analyses
US7148058B2 (en) * 2000-06-05 2006-12-12 Chiron Corporation Protein microarrays on mirrored surfaces for performing proteomic analyses
US7029695B2 (en) 2001-07-10 2006-04-18 Telik, Inc. Therapeutic compositions containing glutathione analogs
US7172905B2 (en) 2001-08-07 2007-02-06 The University Of Chicago Polypeptide immobilization
US7683026B2 (en) * 2003-01-24 2010-03-23 L'oreal Method for synthesizing KPV tripeptide diamide derivatives
NZ555362A (en) * 2005-01-06 2009-05-31 Telik Inc Tripeptide and tetrapeptide thioethers
US20070154963A1 (en) * 2005-12-30 2007-07-05 Danying Cai Method to determine whether a compound is a cellular GSTpi inhibitor
EP1974739A1 (en) * 2007-03-21 2008-10-01 Deutsches Krebsforschungszentrum, Stiftung des öffentlichen Rechts Methods and compounds for modulating inflammatory processes
JP5515738B2 (ja) * 2007-07-25 2014-06-11 味の素株式会社 ジベンゾフルベン誘導体の淘汰方法
EP2381259B1 (en) * 2008-12-24 2016-09-21 Keio University Method for measuring liver disease markers and test method for pharmaceutical preparation
JP2013528213A (ja) 2010-06-07 2013-07-08 テリック，インコーポレイテッド エザチオスタットの錠剤製剤
CN103025753A (zh) * 2010-06-07 2013-04-03 泰立克公司 晶体盐酸依泽替米贝非溶剂化物
US8841476B2 (en) 2010-06-07 2014-09-23 Telik, Inc. Preparation of crystalline ezatiostat hydrochloride ansolvate form D
US8759303B2 (en) 2010-06-07 2014-06-24 Telik, Inc. Compositions and methods for treating myelodysplastic syndrome
RU2639459C2 (ru) 2011-06-21 2017-12-21 Нитто Денко Корпорейшн Апоптоз-индуцирующее средство
JP6340162B2 (ja) 2012-12-20 2018-06-06 日東電工株式会社 アポトーシス誘導剤
CN106573062B (zh) 2014-06-17 2020-08-25 日东电工株式会社 细胞凋亡诱导剂
US10264976B2 (en) 2014-12-26 2019-04-23 The University Of Akron Biocompatible flavonoid compounds for organelle and cell imaging
PT3880212T (pt) 2018-11-16 2024-02-08 Nitto Denko Corp Formulação e métodos de administração de rna de interferência para tumores malignos
EP3973991A4 (en) 2019-05-14 2023-07-05 Keio University ANTI-TUMORS AND COMPOUNDING AGENTS
CN111704566A (zh) * 2020-06-16 2020-09-25 吉尔生化（上海）有限公司 一种N-芴甲氧羰基-γ-（S-三苯甲基-半胱胺基）-L-谷氨酸的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4830624B1 (da) * 1969-06-19 1973-09-21
DE3586772T2 (de) * 1984-07-24 1993-03-04 Coselco Mimotopes Pty Ltd Verfahren zur bestimmung von mimotopen.
HU201094B (en) * 1986-01-23 1990-09-28 Pfizer Process for producing immunostimulant acyltripeptides and pharmaceutical compositions comprising same as active ingredient
US5133866A (en) * 1988-03-24 1992-07-28 Terrapin Technologies, Inc. Method to identify analyte-bending ligands
US4963263A (en) * 1988-03-24 1990-10-16 Terrapin Technologies, Inc. Method of identity analyte-binding peptides
WO1990012088A1 (en) * 1989-04-13 1990-10-18 The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce MONOCLONAL ANTIBODIES TO HUMAN GLUTATHIONE S TRANSFERASE Pi
KR970002904B1 (ko) * 1990-04-26 1997-03-12 센쥬 세이야꾸 가부시끼가이샤 S-저급지방산 글루타티온 유도체
CA2063577C (en) * 1990-05-07 2002-10-01 Tom Cox Method and apparatus for conducting the cytotoxicity assays on tumor cells
IT1248994B (it) * 1990-06-26 1995-02-11 Co Ri T S A S Di Buoso Maria & Processo per la preparazione di s-acil derivati di glutatione composti ottenuti da detto processo e intermedio utile per la loro preparazione
US5204241A (en) * 1990-10-22 1993-04-20 Oxi-Gene Inc. Glutathione-S-transferase mu as a measure of drug resistance
WO1992019767A1 (en) * 1991-04-29 1992-11-12 Terrapin Technologies, Inc. Methods to profile and treat abnormal cells
US5430045A (en) * 1992-04-23 1995-07-04 Free Radical Sciences, Inc. Method of reducing or preventing bone marrow hypoplasia

Also Published As

Publication number Publication date
WO1995008563A1 (en) 1995-03-30
AU7842194A (en) 1995-04-10
AU693807B2 (en) 1998-07-09
PT720620E (pt) 2000-11-30
ATE193302T1 (de) 2000-06-15
DE69424678D1 (de) 2000-06-29
ES2148348T3 (es) 2000-10-16
DE69424678T2 (de) 2000-09-07
CA2171453C (en) 2001-06-12
US5786336A (en) 1998-07-28
JP4025248B2 (ja) 2007-12-19
JP3503641B2 (ja) 2004-03-08
JPH09506336A (ja) 1997-06-24
CA2171453A1 (en) 1995-03-30
EP0720620A1 (en) 1996-07-10
JP2004059586A (ja) 2004-02-26
JP4099430B2 (ja) 2008-06-11
JP2004002442A (ja) 2004-01-08
GR3033230T3 (en) 2000-08-31
EP0720620B1 (en) 2000-05-24

Similar Documents

Publication Publication Date Title
DK0720620T3 (da) Glutathionanaloger og paraloge paneler omfattende glutathionmimetika
ES2173400T3 (es) Composiciones que contienen cinc para administracion oral que incluyen un compuesto de cobre y un aminoacido.
AU8772691A (en) New compounds
FR2575753B1 (fr) Nouveaux derives peptidiques a structure polycyclique azotee, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
PL319833A1 (en) Compounds and composition for carrying active media
PT76860B (en) Dynorphin amide analogs
ATE137763T1 (de) Peptid-verbindungen, deren verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzung
SE8302130L (sv) Farmakologiskt aktiva bifosfonater, forfarande for deras framstellning och farmaceutiska kompositioner innehallande desamma
AU633142B2 (en) Pyrimidine-4,6-dicarboxylic acid diamides, processes for their preparation and the use thereof, and pharmaceuticals based on these compounds
YU45346B (en) Process for obtaining pharmaceutical active 1-substituted oxindole-3-carboxamide
HU9302007D0 (en) Method for producing pharmaceutical preparatives containing 2-|n-(2-amino-ethyl)-amino¨-acetic acid derivatives
KR910700062A (ko) 마가이닌 펩타이드의 결실 동족체
NO20011946L (no) Mangansammensetninger og fremgangsmåter for MRI
NZ337798A (en) Pharmaceutical compositions containing lamivudine
FI901847A0 (fi) Skyddade aminosyror och foerfarande foer deras framstaellning.
JPS6416799A (en) H-pth (1-34) composition and its preparation
ATE103890T1 (de) Neue acylaminosaeurederivate enthaltende arzneimittel und diaetetika.
IE831399L (en) Pharmaceutical composition containing meptazinol and¹ibuprofen.
EP0294667A3 (en) (2-cyano-2-oximinoacetyl)-amino acid derivatives
FUJII et al. Studies on peptides. CXXII. N-succinimidyl-p-(2-nitrovinyl)-benzoate and its m-isomer, as heterobifunctional conjugating reagents for immunoassay
DE60141632D1 (de) Zusammensetzung zur stabilisierung von fettlöslichen vitaminen in wässeriger lösung
藤井信孝 et al. Studies on peptides. CXXII. N-Succinimidyl-p-(2-nitrovinyl)-benzoate and its m-isomer, as heterobifunctional conjugatin reagents for immunoassay.
ATE206048T1 (de) Zur topischen applikation bestimmte diclofenac- lösung
KI'rAGAwA Studies on Peptides. CXXIl.‘" 2l N-Succinimidyl-p-(2-nitrovinyl)-benzoate and Its m-Isomer, as Heterobifunctional Conjugating
EP0305837A3 (en) Thiono-phosphonic-acid ester